# US 2015/0031876 A1 · Method for producing pyrone and pyridone derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0031876 A1
- Document ID: US20150031876A1
- Status: Published application
- Kind: A1
- Application number: 14/478,685
- Filed: 2014-09-05
- Published: 2015-01-29
- Earliest claimed: 2009-03-26
- Assignees: Shionogi & Co., Ltd.
- Applicants: Shionogi & Co., Ltd.
- Inventors: Yukihito Sumino; Kazuya Okamoto; Moriyasu Masui; Toshiyuki Akiyama
- Web page: https://patentgrep.com/patent/US20150031876A1

## CPC

- C07D 498/14: Ortho-condensed systems
- C07D 213/80: in position 3
- C07D 309/32: having two double bonds between ring members or between ring members and non-ring members
- C07D 309/40: Oxygen atoms attached in positions 3 and 4, e.g. maltol
- C07D 405/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D 471/04: Ortho-condensed systems
- C07D 471/14: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

The present invention provides a pyrone derivative and a pyridone derivative, which are novel intermediates for synthesizing an anti-influenza drug, a method of producing the same, and a method of using the same.

## Claims

### Claim at position 1

1-18. (canceled)

### Claim 19

A method of producing a compound shown by formula (X3) or formula (XA3), or a salt thereof:
wherein
R1d is hydrogen, halogen, lower alkyloxy optionally substituted by substituent E, or carbocyclyl lower alkyloxy optionally substituted by substituent E, heterocyclyl lower alkyloxy optionally substituted by substituent E, or —OSi(R1e)3,
R1es are each independently lower alkyl optionally substituted by substituent E, carbocyclyl optionally substituted by substituent E, heterocyclyl optionally substituted by substituent E, carbocyclyl lower alkyl optionally substituted by substituent E or heterocyclyl lower alkyl optionally substituted by substituent E,
R2d is hydrogen, lower alkyl optionally substituted by substituent E, carbocyclyl lower alkyl optionally substituted by substituent E, or heterocyclyl lower alkyl optionally substituted by substituent E,
comprising reacting a compound shown by formula (X2):
wherein:
R3d is hydrogen, lower alkyl optionally substituted by substituent E, N(R3e)2, or —OR3e,
R3es are each independently lower alkyl optionally substituted by substituent E, or may be taken together to form a heterocycle;
Substituent E: halogen, cyano, hydroxy, carboxy, formyl, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, carbocyclyl optionally substituted by substituent F, heterocyclyl optionally substituted by substituent F, carbocyclyl lower alkyloxy optionally substituted by substituent F, heterocyclyl lower alkyloxy optionally substituted by substituent F, carbocyclyl lower alkylthio optionally substituted by substituent F, heterocyclyl lower alkylthio optionally substituted by substituent F, carbocyclyl lower alkylamino optionally substituted by substituent F, heterocyclyl lower alkylamino optionally substituted by substituent F, carbocyclyloxy optionally substituted by substituent F, heterocyclyloxy optionally substituted by substituent F, carbocyclylcarbonyl optionally substituted by substituent F, heterocyclylcarbonyl optionally substituted by substituent F, carbocyclylaminocarbonyl optionally substituted by substituent F, heterocyclylaminocarbonyl optionally substituted by substituent F, halogeno lower alkyloxy, lower alkyloxy lower alkyl, lower alkyloxy lower alkyloxy, lower alkylcarbonyl, lower alkyloxycarbonyl, lower alkyloxycarbonylamino, lower alkylamino, lower alkylcarbonylamino, lower alkylaminocarbonyl, lower alkylsulfonyl, and lower alkylsulfonylamino;
Substituent F: halogen, hydroxy, carboxy, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, and amino protective group); and
wavy line is E form and/or Z form or the mixture thereof;
with a compound shown by formula (V2) or formula (VA2):
wherein
R4d is lower alkyl optionally substituted by substituent E, carbocyclyl lower alkyl optionally substituted by substituent E, or heterocyclyl lower alkyl optionally substituted by substituent E,
R4es are each independently hydrogen, lower alkyl optionally substituted by substituent E, carbocyclyl optionally substituted by substituent E, or heterocyclyl optionally substituted by substituent E,
R5d is hydrogen, halogen, lower alkyloxy optionally substituted by substituent E, or —O—SO2—R5e,
R5e is lower alkyl optionally substituted by substituent E, carbocyclyl optionally substituted by substituent E, heterocyclyl optionally substituted by substituent E, carbocyclyl lower alkyl optionally substituted by substituent E, or heterocyclyl lower alkyl optionally substituted by substituent E and
substituent E is defined above.

### Claim 20 (depends on 19)

A method according to claim 19, wherein the compound shown by formula (X2) is obtained by reacting a compound shown by formula (X1):
(wherein each symbol is defined in claim 19)
with a compound shown by formula (VI):
(wherein Pd is lower alkyl optionally substituted by substituent E, and R3d and substituent E are defined in claim 19).

### Claim 21 (depends on 19)

A method according to claim 19, wherein the compound shown by formula (X2) is obtained by reacting a compound shown by formula (Z1):
(wherein each symbol is defined in claim 19)
with a compound shown by formula (Z2):
(wherein each symbol is defined in claim 19).

### Claim 22

A compound shown by formula (X3), or a pharmaceutically acceptable salt thereof or solvate thereof:
wherein
R1d is hydrogen, halogen, lower alkyloxy optionally substituted by substituent E, or carbocyclyl lower alkyloxy optionally substituted by substituent E, heterocyclyl lower alkyloxy optionally substituted by substituent E, or —OSi(R1e)3,
R1es are each independently lower alkyl optionally substituted by substituent E, carbocyclyl optionally substituted by substituent E, heterocyclyl optionally substituted by substituent E, carbocyclyl lower alkyl optionally substituted by substituent E or heterocyclyl lower alkyl optionally substituted by substituent E,
R2d is hydrogen, lower alkyl optionally substituted by substituent E, carbocyclyl lower alkyl optionally substituted by substituent E, or heterocyclyl lower alkyl optionally substituted by substituent E,
R4d is lower alkyl optionally substituted by substituent E, carbocyclyl lower alkyl optionally substituted by substituent E, or heterocyclyl lower alkyl optionally substituted by substituent E,
Substituent E: halogen, cyano, hydroxy, carboxy, formyl, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, carbocyclyl optionally substituted by substituent F, heterocyclyl optionally substituted by substituent F, carbocyclyl lower alkyloxy optionally substituted by substituent F, heterocyclyl lower alkyloxy optionally substituted by substituent F, carbocyclyl lower alkylthio optionally substituted by substituent F, heterocyclyl lower alkylthio optionally substituted by substituent F, carbocyclyl lower alkylamino optionally substituted by substituent F, heterocyclyl lower alkylamino optionally substituted by substituent F, carbocyclyloxy optionally substituted by substituent F, heterocyclyloxy optionally substituted by substituent F, carbocyclylcarbonyl optionally substituted by substituent F, heterocyclylcarbonyl optionally substituted by substituent F, carbocyclylaminocarbonyl optionally substituted by substituent F, heterocyclylaminocarbonyl optionally substituted by substituent F, halogeno lower alkyloxy, lower alkyloxy lower alkyl, lower alkyloxy lower alkyloxy, lower alkylcarbonyl, lower alkyloxycarbonyl, lower alkyloxycarbonylamino, lower alkylamino, lower alkylcarbonylamino, lower alkylaminocarbonyl, lower alkylsulfonyl, and lower alkylsulfonylamino:
Substituent F: halogen, hydroxy, carboxy, amino, oxo, nitro, lower alkyl, halogeno lower alkyl, lower alkyloxy, and amino protective group); and
wavy line is E form and/or Z form or the mixture thereof;
with a compound shown by formula (V2) or formula (VA2):
wherein
R4d is lower alkyl optionally substituted by substituent E, carbocyclyl lower alkyl optionally substituted by substituent E, or heterocyclyl lower alkyl optionally substituted by substituent E,
R4es are each independently hydrogen, lower alkyl optionally substituted by substituent E, carbocyclyl optionally substituted by substituent E, or heterocyclyl optionally substituted by substituent E,
R5d is hydrogen, halogen, lower alkyloxy optionally substituted by substituent E, or —O—SO2—R5e,
R5e is lower alkyl optionally substituted by substituent E, carbocyclyl optionally substituted by substituent E, heterocyclyl optionally substituted by substituent E, carbocyclyl lower alkyl optionally substituted by substituent E, or heterocyclyl lower alkyl optionally substituted by substituent E and
substituent E is defined above.

### Claim 23

A crystal of a compound shown by formula (1D) or a solvate thereof:
(wherein Me is a methyl group, and Bn is a benzyl group),
wherein the compound has a peak at a diffraction angle (2θ): 7.9°±0.2°, 10.0°±0.2°, 11.5°±0.2°, 20.0°±0.2°, 23.4°±0.2° and 34.0°±0.2° in a powder X-ray diffraction spectrum.

### Claim 24

A crystal of a compound represented by formula (2D) or a solvate thereof:
(wherein Me is a methyl group, Et is an ethyl group, and Bn is a benzyl group), wherein the compound has a peak at a diffraction angle (2θ): 17.6°±0.2°, 25.2°±0.2°, 26.4°±0.2° and 28.1°±0.2° in a powder X-ray diffraction spectrum.

### Claim 25

A crystal of a compound shown by formula (9C′) or a solvate thereof:
(wherein Me is a methyl group, and Bn is a benzyl group),
wherein the compound has a peak at a diffraction angle (2θ): 14.2°±0.2°, 16.0°±0.2°, 22.0°±0.2°, 22.2°±0.2°, 24.4°±0.2° and 25.9°±0.2° in a powder X-ray diffraction spectrum.

### Claim 26 (depends on 23)

A crystal according to claim 23, which is characterized by a powder X-ray diffraction spectrum which is substantially consistent with FIG. 1.

### Claim 27 (depends on 24)

A crystal according to claim 24, which is characterized by a powder X-ray diffraction spectrum which is substantially consistent with FIG. 2.

### Claim 28 (depends on 25)

A crystal according to claim 25, which is characterized by a powder X-ray diffraction spectrum which is substantially consistent with FIG. 3.
